Strategies for efficient computation of the expected value of partial perfect information

Medical Decision Making

Volumn 34, Issue 3, 2014, Pages 327-342

  Madan, Jason ^a,e   Ades, Anthony E ^a   Price, Malcolm ^a,f   Maitland, Kathryn ^b,c   Jemutai, Julie ^c   Revill, Paul ^d   Welton, Nicky J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^d UNIVERSITY OF YORK   (United Kingdom)

^e UNIVERSITY OF WARWICK   (United Kingdom)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Bayesian methods; cost effectiveness analysis; value of information

Indexed keywords

BIOLOGY; DECISION MAKING; HEALTH CARE PLANNING; MONTE CARLO METHOD; UNCERTAINTY;

COMPUTATIONAL BIOLOGY; DECISION MAKING; HEALTH PRIORITIES; MONTE CARLO METHOD; UNCERTAINTY;

EID: 84898777327     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X13514774     Document Type: Article

References (23)

1. Schlaifer R New York: McGraw-Hill ; 1959 :
2. Raïffa H, Schlaifer R New York: Wiley ; 2000 :
3. Gelman A, Carlin JB, Stern HS, Rubin DB 2 nd ed.New York: Taylor & Francis; 2003. New York: Taylor & Francis ; 2003 :
4. Felli JC, Hazen GB. Sensitivity analysis and the expected value of perfect information. Med Decis Making. 1998 ; 18 (1). 95-109
5. Thompson KM, Evans JS. The value of improved national exposure information for perchloroethylene (Perc): a case study for dry cleaners. Risk Anal. 1997 ; 17 (2). 253-71
6. Sutton AJ, Welton NJ, Cooper NJ, Abrams KR, Ades AE New York: Wiley ; 2012 :
7. Brennan A, Kharroubi S, O'Hagan A, Chilcott J. Calculating partial expected value of perfect information via Monte Carlo sampling algorithms. Med Decis Making. 2007 ; 27 (4). 448-70
8. Oakley JE, Brennan A, Tappenden P, Chilcott J. Simulation sample sizes for Monte Carlo partial EVPI calculations. J Health Econ. 2010 ; 29 (3). 468-77
9. Ades AE, Lu G, Claxton K. Expected value of sample information calculations in medical decision modeling. Med Decis Making. 2004 ; 24 (2). 207-27
10. Dondorp AM, Fanello CI, Hendriksen IC, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2010 ; 376 (9753). 1647-57
11. Brewster DR, Kwiatkowski D, White NJ. Neurological sequelae of cerebral malaria in children. Lancet. 1990 ; 336 (8722). 1039-43
12. Mung'Ala-Odera V, Snow RW, Newton CR. The burden of the neurocognitive impairment associated with Plasmodium falciparum malaria in Sub-Saharan Africa. Am J Trop Med Hygiene. 2004 ; 71: 64-70
13. Maitland K, Pamba A, Newton CRJC, Levin M. Response to volume resuscitation in children with severe malaria. Pediatr Crit Care Med. 2003 ; 4 (4). 426-31
14. Maitland K, Pamba A, English M, et al. Pre-transfusion management of children with severe malarial anaemia: a randomised controlled trial of intravascular volume expansion. Br J Haematol. 2005 ; 128 (3). 393-400
15. Akech S, Gwer S, Richard I, et al. Volume expansion with albumin compared to gelofusine in children with severe malaria: results of a controlled trial. Plos Clin Trials. 2006 ; 1 (5). e21
16. Maitland K, Kiguli S, Opoka RO, et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011 ; 364 (26). 2483-95
17. Welton NJ, Ades AE, Caldwell DM, Peters TJ. Research prioritization based on expected value of partial perfect information: a case-study on interventions to increase uptake of breast cancer screening. J R Stat Soc A Stat. 2008 ; 171: 807-34
18. Harrell FE New York: Springer; ; 2010 :
19. Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS: a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput. 2000 ; 10 (4). 325-37
20. Stevenson MD, Oakley J, Chilcott JB. Gaussian process modeling in conjunction with individual patient simulation modeling: a case study describing the calculation of cost-effectiveness ratios for the treatment of established osteoporosis. Med Decis Making. 2004 ; 24 (1). 89-100
21. Tappenden P, Chilcott JB, Eggington S, Oakley J, McCabe C. Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-beta and glatiramer acetate for multiple sclerosis. Health Technol Asses. 2004 ; 8 (27). 1-78
22. Turner RM, Spiegelhalter DJ, Smith GCS, Thompson SG. Bias modelling in evidence synthesis. J R Stat Soc Ser A Stat Soc. 2009 ; 172 (1). 21-47
23. Caro JJ, Briggs AH, Siebert U, Kuntz KM. Modeling good research practices: overview. A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1. Med Decis Making. 2012 ; 32 (5). 667-77